Katherine R Tuttle. Show Affiliations »
Abstract
Mesh： See more » AtorvastatinCardiovascular Diseases/etiologyCardiovascular Diseases/mortalityCardiovascular Diseases/prevention & controlComputer SimulationDatabases as TopicDiabetes Mellitus, Type 2/complicationsDiabetes Mellitus, Type 2/mortalityHeptanoic Acids/therapeutic useHumansHydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic useKidney Failure, Chronic/complicationsKidney Failure, Chronic/mortalityKidney Failure, Chronic/therapyMyocardial Infarction/etiologyMyocardial Infarction/prevention & controlPyrroles/therapeutic useRandomized Controlled Trials as TopicRenal Dialysis/adverse effectsRisk AssessmentRisk FactorsStroke/etiologyStroke/prevention & controlTime FactorsTreatment Outcome
Substances： See more » Heptanoic AcidsHydroxymethylglutaryl-CoA Reductase InhibitorsPyrrolesAtorvastatin
Year: 2010 PMID： 20360306 DOI： 10.2215/CJN.01880310
Source DB: PubMed Journal: Clin J Am Soc Nephrol ISSN： 1555-9041 Impact factor: 8.237